Article Versions Notes

Mlyuka HJ, Kilonzi M, Mutagonda RF, Chirande L, Mikomangwa WP, Myemba DT, Sambayi G, Mwakawanga DL, Ndunguru J, Jonathan A, et al. Barriers and Facilitators of Availability of Hydroxyurea for Sickle Cell Disease in Tanzania; A Qualitative Study of Pharmaceutical Manufacturers, Importers, and Regulators. Healthcare. 2022; 10(11):2223. https://doi.org/10.3390/healthcare10112223

Mlyuka, Hamu J., Manase Kilonzi, Ritah F. Mutagonda, Lulu Chirande, Wigilya P. Mikomangwa, David T. Myemba, Godfrey Sambayi, Dorkasi L. Mwakawanga, Joyce Ndunguru, Agnes Jonathan, and et al. 2022. "Barriers and Facilitators of Availability of Hydroxyurea for Sickle Cell Disease in Tanzania; A Qualitative Study of Pharmaceutical Manufacturers, Importers, and Regulators" Healthcare 10, no. 11: 2223. https://doi.org/10.3390/healthcare10112223

Mlyuka, H. J., Kilonzi, M., Mutagonda, R. F., Chirande, L., Mikomangwa, W. P., Myemba, D. T., Sambayi, G., Mwakawanga, D. L., Ndunguru, J., Jonathan, A., Makani, J., Ruggajo, P., Minja, I. K., Balandya, E., & Kamuhabwa, A. A. R. (2022). Barriers and Facilitators of Availability of Hydroxyurea for Sickle Cell Disease in Tanzania; A Qualitative Study of Pharmaceutical Manufacturers, Importers, and Regulators. Healthcare, 10(11), 2223. https://doi.org/10.3390/healthcare10112223